Braze raised guidance again; why should lifecycle teams care?
Braze just printed its fourth straight quarter of accelerating revenue growth, raised guidance for the second time this year, and posted record free cash flow. The stock is still trading roughly 37% below its 52-week high.
For the lifecycle marketers evaluating customer engagement platforms right now, that gap matters less than the headlines suggest.
What Braze actually reported
The Q1 fiscal 2027 numbers, released May 27, were strong by any reasonable read:
Revenue of $211 million, up 30% year over year, and the fourth straight quarter of accelerating growth.
Dollar-based net retention up to 110% across all customers, 111% for large accounts.
Customers spending more than $500,000 a year grew 33% year over year and now make up 65% of ARR.
Six new deals over $1 million in a single quarter, including a “milestone” win at a prominent AI lab.
Record free cash flow of $27 million.
Raised FY27 revenue guidance to $895 million to $899 million, with a reiterated 400 basis points of operating margin expansion.
The customer logos called out on the earnings call, Cleo, ClassPass, Denny's, Regal Cinemas, Salomon, and Subway among them, are exactly the kind of mid-market and enterprise wins that lifecycle teams care about. The Cleo case study cited an 81% decline in unsubscribes after rebuilding the welcome series with BrazeAI Operator. Luxury Escapes reported a 10% lift in revenue per user from agentic cohorting.
These are operational results, not slideware. Programs are shipping and producing measurable lift.
The stock chart says something different
And yet, BRZE as a stock is down roughly 29% year to date in 2026 and was off about 60% from its prior peak at the February low. Trailing EV/Revenue sits around 2.9x. For a SaaS business growing 30% with improving retention and accelerating free cash flow, that multiple is unusually compressed.
Wall Street analysts have not abandoned the name. The consensus rating remains Buy with an average price target in the $34 to $38 range, implying somewhere between 50% and 75% upside from recent levels.
Three reasons the gap exists
SaaS multiples got cut in half. The median public SaaS EV/Revenue multiple fell from roughly 6x to 7x entering 2026 to about 3.4x by March, the largest sector-wide repricing since 2022. The story driving most of that compression is GenAI disruption fear. The argument goes that foundation models will commoditize the workflow layer above customer data, leaving incumbents like Braze stuck defending their take rate. Whether that thesis plays out is debatable, but it is being priced in regardless of any single company's quarterly results.
The Rule of 40 reweighting hit growth-first SaaS hardest. In 2021, growth was worth roughly 2.5x more than profitability in SaaS valuations. By 2026, the two carry similar weight, and investors are anchoring on Rule of 40. Braze posted about 30% growth plus 5% non-GAAP operating margin in Q1, which clears 40 in spirit but is below the comfort zone for a market that wants 35%+ growth and 15%+ margins. Gross margin also slipped from 69.3% to 67.4%, driven by premium messaging volume and the personnel ramp for OfferFit-derived Decisioning Studio. That dip gave bears something concrete to point at on an otherwise clean quarter.
OfferFit integration and a CFO transition added execution risk. Braze's $325 million OfferFit acquisition closed in mid-2025 and is being delivered through forward-deployed engineers, which is gating Decisioning Studio bookings in some regions. Management said start-date delays were cut roughly in half during Q1, but supply constraints remain a real overhang. On top of that, CFO Isabelle Winkles announced her departure on the same call. Markets price uncertainty into the valuation, even when the operating fundamentals look fine.
What this means if you are evaluating Braze right now
Three takeaways for lifecycle teams sitting in vendor evaluations or annual renewals.
Read the operating fundamentals, not the stock chart. A depressed share price reflects investor positioning across an entire category. The product roadmap, the retention number, the customer expansion data, and the support model are what determine whether a platform will serve your program over a three-year contract. On those dimensions, Braze just turned in a strong quarter.
Multi-year commitments deserve more scrutiny than usual. Vendor stability questions get sharper when a sector is under pressure. Ask about RPO duration, the CFO transition, OfferFit integration timelines, and the roadmap for Decisioning Studio capacity in your region. These are reasonable diligence questions during any renewal, and the operating context makes them more relevant now.
Stock-price drift can create commercial leverage. Public vendors under pressure are often more willing to negotiate on price, multi-year terms, professional services credit, and roadmap commitments. Treat this as a healthy time to revisit pricing and contract structure, regardless of whether you are switching platforms.
If you are weighing a move to or from Braze, our blog on whether to switch ESPs or fix what you have lays out the decision framework we use with clients before any migration starts. For teams who have already decided Braze is the right destination, our Braze migration practice covers the operational playbook end to end.
The takeaway
Strong operating quarters do not always translate into strong stock prices, especially when an entire software category is being repriced around an AI thesis. Braze just gave the market clean numbers and raised guidance. The stock has not responded. For investors, that gap is a debate worth having. For lifecycle teams evaluating platforms, the more useful question is whether the product, the support, and the roadmap will deliver against your program goals. Q1 is a fair piece of evidence that they will.
A broader view on how we think about platform selection across Braze, Klaviyo, Iterable, Customer.io, and other engagement platforms lives in our practical guide to the best ESPs for ecommerce brands.
This post analyzes publicly available company disclosures and market data for the purpose of platform evaluation by marketing teams. It is not investment advice.
